Atara Biotherapeutics (ATRA) Treasury Shares (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Treasury Shares of $322690.0 for Q1 2026, down 52.4% on a YoY basis from $677948.0 in Q1 2025, and up 49.36% quarter-over-quarter from $216048.0 in Q4 2025.
Atara Biotherapeutics (ATRA) Treasury Shares (2013 - 2026) Analysis & Trends
Atara Biotherapeutics has reported Treasury Shares for 14 years, with the latest figure at $322690.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 52.4% year-over-year to $322690.0; the trailing twelve-month figure through Mar 2026 stood at $322690.0 (down 52.4% YoY), and the FY2025 full-year result was $216048.0, down 47.87% from the prior year.
- Treasury Shares for Q1 2026 stood at $322690.0, up from $216048.0 in the prior quarter.
- The five-year high for Treasury Shares was $16.5 million in Q1 2024, with the low at $216048.0 in Q4 2025.
- Historically, Treasury Shares has averaged $4.7 million across 5 years, with a median of $677948.0 in 2025.
- Annual changes were most pronounced in 2023 — Treasury Shares plunged 96.26% — and 2024, when it soared 65.32%.
- Atara Biotherapeutics' Treasury Shares stood at $6.7 million in 2022, then sank by 96.26% to $250709.0 in 2023, then soared by 65.32% to $414470.0 in 2024, then sank by 47.87% to $216048.0 in 2025, then surged by 49.36% to $322690.0 in 2026.
- The last three Treasury Shares figures came in at $322690.0 (Q1 2026), $216048.0 (Q4 2025), and $278347.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | 322,690.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 322,690.00 |
| Mar 31, 2026 | 322,690.00 |
| Dec 31, 2025 | 216,048.00 |
| Dec 31, 2025 | 216,048.00 |
| Sep 30, 2025 | 278,347.00 |
| Sep 30, 2025 | 278,347.00 |
| Jun 30, 2025 | 503,640.00 |
| Jun 30, 2025 | 503,640.00 |
| Mar 31, 2025 | 677,948.00 |
| Mar 31, 2025 | 677,948.00 |
| Dec 31, 2024 | 414,470.00 |
| Dec 31, 2024 | 414,470.00 |
| Sep 30, 2024 | 517,400.00 |
| Sep 30, 2024 | 517,400.00 |
| Jun 30, 2024 | 554,938.00 |
| Jun 30, 2024 | 554,938.00 |
| Mar 31, 2024 | 16.47 Mn |
| Mar 31, 2024 | 16.47 Mn |
| Dec 31, 2023 | 250,709.00 |
| Dec 31, 2023 | 250,709.00 |